HYFT
MindWalk Holdings Corp.
HYFT offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
OSCR
Oscar Health, Inc.
OSCR has the edge over HYFT overall, supported by stronger fundamentals and lower modeled downside.
HYFT Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Weak | |
| Strong |
HYFT's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
OSCR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
OSCR's revenue, profitability, cash flow and balance sheet are all currently healthy.
HYFT PE Valuation
HYFT has no meaningful PE right now: it lost money over the past year.
OSCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $31.94 | — |
| Current | 13x | $31.94 | — |
| Cheap | 21x | $52.73 | +65% |
| Fair | 35x | $87.23 | +173% |
| Expensive | 130x | $322 | +907% |
Historical ranges are pointers, not guarantees.
OSCR's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
HYFT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Growth | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect HYFT's losses to grow, with revenue growing.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
OSCR has the edge over HYFT on the outlook, with more favorable earnings and profitability expectations.
HYFT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2022 | -$0.75 | -$0.34 |
| Q2 2022 | -$0.60 | -$0.29 |
| Q1 2022 | -$0.65 | -$0.50 |
| Q4 2021 | -$0.57 | -$0.44 |
| Q3 2021 | -$0.41 | -$0.23 |
| Q2 2021 | -$0.31 | -$0.05 |
| Q1 2021 | -$0.15 | +$0.26 |
| Q4 2020 | -$0.13 | +$0.31 |
OSCR has the stronger earnings trend. Trailing diluted EPS is down 135% for HYFT versus OSCR up 147%.
OSCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.61 | +5.6% |
| Q3 2026 | $2.47 | +$3.47 |
| Q2 2026 | $1.45 | +$2.14 |
| Q1 2026 | -$0.54 | -235% |
| Q4 2025 | -$1.69 | -1790% |
| Q3 2025 | -$1.00 | -$0.92 |
| Q2 2025 | -$0.69 | -$0.54 |
| Q1 2025 | $0.40 | +$0.82 |
| Q4 2024 | $0.10 | +$1.32 |
OSCR has returned to profit: it earned $2.47 per share over the past year, after losing money the year before.
HYFT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.7M | +23% |
| Q2 2026 | $2.9M | -42% |
| Q1 2026 | $2.9M | -32% |
| Q4 2025 | $2.9M | -33% |
| Q3 2025 | $2.2M | -40% |
| Q2 2025 | $4.9M | +8.1% |
| Q1 2025 | $4.3M | -1.1% |
| Q4 2024 | $4.3M | -0.4% |
HYFT's revenue is recovering but still below its 2025 peak: $3M last quarter, up 23% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -160% | -28 points |
| Q2 2026 | -105% | -78 points |
| Q1 2026 | -95% | +304 points |
| Q4 2025 | -77% | -28 points |
| Q3 2025 | -132% | -42 points |
| Q2 2025 | -27% | +264 points |
| Q1 2025 | -399% | -343 points |
| Q4 2024 | -50% | -16 points |
HYFT's operating margin was −160% last quarter, down 28 points from the same quarter a year ago.
OSCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +72% |
| Q2 2026 | $4.9B | +70% |
| Q1 2026 | $4.6B | +53% |
| Q4 2025 | $2.8B | +17% |
| Q3 2025 | $3B | +23% |
| Q2 2025 | $2.9B | +29% |
| Q1 2025 | $3B | +42% |
| Q4 2024 | $2.4B | +67% |
OSCR has the edge over HYFT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +7.8 points |
| Q2 2026 | 8% | +16 points |
| Q1 2026 | 15% | +5.4 points |
| Q4 2025 | -12% | -5.7 points |
| Q3 2025 | -4.3% | -2.3 points |
| Q2 2025 | -8.1% | -11 points |
| Q1 2025 | 9.8% | +1.1 points |
| Q4 2024 | -6.2% | +4 points |
OSCR has the edge over HYFT on profitability, with a higher operating margin.
HYFT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$2.9M | +$218.3K |
| Q2 2026 | -$1.8M | -$719.4K |
| Q1 2026 | -$2.1M | -$1.2M |
| Q4 2025 | -$2.1M | -$447.1K |
| Q3 2025 | -$3.2M | -$1.7M |
| Q2 2025 | -$1.1M | +$1.6M |
| Q1 2025 | -$924.5K | -$572.3K |
| Q4 2024 | -$1.6M | -$1.4M |
HYFT has burned cash in almost every quarter: −$9M over the past year, against −$7M the year before.
OSCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -$238.2M |
| Q2 2026 | $2.1B | +316% |
| Q1 2026 | $2.6B | +200% |
| Q4 2025 | $662.8M | +95% |
| Q3 2025 | -$973.7M | -$466M |
| Q2 2025 | $499.8M | +2.1% |
| Q1 2025 | $869.5M | +38% |
| Q4 2024 | $340M | +17% |
OSCR has the edge over HYFT on cash generation, producing positive trailing cash flow while its opponent burns cash.
HYFT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +95.2K shares |
| 1 year | +1.4% | +653K shares |
| 3 years | +87% | +21.8M shares |
| 5 years | +177% | +29.9M shares |
| Available history | +244% | +33.2M shares |
HYFT has the edge over OSCR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
OSCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +13M shares |
| 1 year | +34% | +87.2M shares |
| 3 years | +55% | +123M shares |
| 5 years | +66% | +138M shares |
| Available history | +71% | +143M shares |
OSCR has 346M diluted shares, up 34% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
HYFT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2021 | -7.4x | Net Cash |
| Q4 2020 | -5.5x | Net Cash |
| Q3 2020 | -0.8x | Net Cash |
HYFT has more cash than debt.
OSCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.2x | Net Cash |
| Q2 2026 | -5.5x | Net Cash |
| Q1 2026 | -110.0x | Net Cash |
| Q1 2025 | -9.7x | Net Cash |
| Q4 2024 | -13.7x | Net Cash |
| Q3 2024 | -10.1x | Net Cash |
| Q2 2024 | -24.0x | Net Cash |
| Q1 2024 | -217.7x | Net Cash |
OSCR has more cash than debt.
HYFT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.9 | Neutral |
| Stochastic | 8.2 | Oversold |
HYFT's weekly RSI is 36 (neutral) and its Stochastic is 8 (oversold).
OSCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 44.9 | Neutral |
OSCR's weekly RSI is 59 (neutral) and its Stochastic is 45 (neutral).
HYFT PE vs Healthcare Sector
HYFT has no meaningful PE right now: it lost money over the past year.
OSCR PE vs Healthcare Sector
| Metric | OSCR | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 50% below |
| PE % | 3 | 35 | 32 pts below |
OSCR is trading at 13x earnings, a 50% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
HYFT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.23 | 19% below |
| 20 week MA | $1.32 | 24% below |
| 50 week MA | $1.45 | 31% below |
| 100 week MA | $1.28 | 22% below |
| 200 week MA | $1.56 | 36% below |
HYFT is in a downtrend: it's below all five of its weekly moving averages, and 36% below its 200-week average.
OSCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.2 | 2.3% above |
| 20 week MA | $31.1 | 2.8% above |
| 50 week MA | $22.9 | 39% above |
| 100 week MA | $19.3 | 65% above |
| 200 week MA | $15.5 | 106% above |
OSCR has the edge over HYFT on trend strength, trading above more of its moving averages.
HYFT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.20 | $16.4 | +645% |
| 2021 | $16.4 | $5.36 | -67% |
| 2022 | $5.36 | $5.72 | +6.7% |
| 2023 | $5.72 | $1.71 | -70% |
| 2024 | $1.71 | $0.41 | -76% |
| 2025 | $0.41 | $1.70 | +315% |
| 2026 YTD | $1.70 | $1.00 | -41% |
HYFT's yearly returns have swung widely, from +645% in 2020 to −76% in 2024. It's down 41% so far in 2026.
OSCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $31.0 | $8.02 | -74% |
| 2022 | $8.02 | $2.21 | -72% |
| 2023 | $2.21 | $9.15 | +314% |
| 2024 | $9.15 | $13.8 | +51% |
| 2025 | $13.8 | $14.9 | +8% |
| 2026 YTD | $14.9 | $31.9 | +114% |
OSCR has the edge over HYFT on returns for 2026, with the stronger performance.